Asia Pacific Minimally Invasive Surgical Instruments Market Size, Share, Opportunities, And Trends By Product Type (Surgical Equipment, Monitoring & Visualization Equipment, Electrosurgical Systems), By Application (Cardiothoracic Surgery, Gastrointestinal Surgery, Orthopedic Surgery, Gynecological Surgery, Cosmetic/Bariatric Surgery, Vascular Surgery, Urological Surgery, Others) -Forecasts From 2022 To 2027

Published:  Mar 2020 Report Code: KSI061611007 Pages: 114

The Asia Pacific Minimally Invasive Surgical Instruments Market was valued at US$3.303 billion in 2017 and is projected to expand at a CAGR of 9.91% over the forecast period to reach US$5.824 billion by 2023. This research study examines the Asia Pacific Minimally Invasive Surgical Instruments market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report.  The report also analyzes key players in the Asia Pacific Minimally Invasive Surgical Instruments market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as base year.        

The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of the Asia Pacific Minimally Invasive Surgical Instruments market, offering stakeholders a better understanding of the key factors affecting the overall market environment.

The first step towards determining the Asia Pacific Minimally Invasive Surgical Instruments market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Asia Pacific Minimally Invasive Surgical Instruments value chain, who are C-Level Executives, Directors, and Managers among others across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Segments covered under the Asia Pacific Minimally Invasive Surgical Instruments market report are as below:

By Product Type

Surgical Equipment

Monitoring & Visualization Equipment

Electrosurgical Systems



By Application

Cardiothoracic Surgery 

Gastrointestinal Surgery 

Orthopedic Surgery 

Gynecological Surgery 

Cosmetic/Bariatric Surgery 

Vascular Surgery 

Urological Surgery 




By Geography

Asia Pacific









Key industry players profiled as part of this section are Medtronic plc, Ethicon, Inc., Aesculap, Inc., Stryker Corporation, and Smith & Nephew, ConMed Corporation, Abbott Laboratories, Applied Biomedical Resources Corporation, Microline Surgical, and Zimmer Biomet.

The report’s target audience is as below:




Service Providers

Government Agencies

Research Organizations


1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Asia Pacific Minimally Invasive Surgical Instruments Market Forecast by Product Type (US$ Billion)
5.1. Introduction
5.2. Surgical Equipment
5.3. Monitoring & Visualization Equipment
5.4. Electrosurgical Systems
6. Asia Pacific Minimally Invasive Surgical Instruments Market Forecast by Application (US$ Billion)
6.1. Introduction
6.2. Cardiothoracic Surgery 
6.3. Gastrointestinal Surgery 
6.4. Orthopedic Surgery 
6.5. Gynecological Surgery 
6.6. Cosmetic/Bariatric Surgery 
6.7. Vascular Surgery 
6.8. Urological Surgery 
6.9. Others
7. Asia Pacific Minimally Invasive Surgical Instruments Market Forecast by Geography (US$ Billion)
7.1. Introduction
7.2. Asia Pacific
7.2.1. China
7.2.2. Japan
7.2.3. India
7.2.4. Australia
7.2.5. Others
8. Competitive Intelligence
8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. Company Profiles
9.1. Ethicon, Inc.
9.1.1. Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Key Developments
9.2. Zimmer, Inc.
9.2.1. Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Key Developments
9.3. Medtronic Plc. 
9.3.1. Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Key Developments
9.4. Smith and Nephew
9.4.1. Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Key Developments
9.5. Stryker
9.5.1. Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Key Developments
9.6. CONMED Corporation
9.6.1. Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Key Developments
9.7. Aesculap, Inc.
9.7.1. Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Key Developments
9.8. Abbott Laboratories
9.8.1. Overview
9.8.2. Financials
9.8.3. Products and Services
9.8.4. Key Developments
9.9. Applied Biomedical Resources Corporation
9.9.1. Overview
9.9.2. Financials
9.9.3. Products and Services
9.9.4. Key Developments
9.10. Microline Surgical
9.10.1. Overview
9.10.2. Financials
9.10.3. Products and Services
9.10.4. Key Developments
9.11. Zimmer Biomet
9.11.1. Overview
9.11.2. Financials
9.11.3. Products and Services
9.11.4. Key Developments
List of Tables
List of Figures

Ethicon, Inc.
Zimmer, Inc.
Medtronic Plc. 
Smith and Nephew
CONMED Corporation
Aesculap, Inc.
Abbott Laboratories
Applied Biomedical Resources Corporation
Microline Surgical
Zimmer Biomet


Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


We are in compliance with the global privacy laws.

Connect With Us